vantocil has been researched along with Osteomyelitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sams-Dodd, F; Sams-Dodd, J | 1 |
| Kuznetsov, NA; Mil'chakov, AA; Nikitin, VG; Teleshova, EB | 1 |
| Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| de Hoog, GS; Goudswaard, WB; Kampinga, GA; Kooijman, CM; Reijnen, MM | 1 |
1 review(s) available for vantocil and Osteomyelitis
| Article | Year |
|---|---|
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
3 other study(ies) available for vantocil and Osteomyelitis
| Article | Year |
|---|---|
Micropore Particle Technology Promotes Wound Healing, Whereas Polyhexamethylene Biguanide Causes Tissue Degeneration: A Case Report.
Topics: Abscess; Aged; Anti-Infective Agents, Local; Biguanides; Biomedical Technology; Debridement; Exudates and Transudates; Female; Humans; Osteomyelitis; Powders; Pressure Ulcer; Spinal Cord Injuries; Wound Healing; Wound Infection | 2020 |
[Biodegradable implants and antiseptics for the treatment of postoperative osteomyelitis].
Topics: Absorbable Implants; Administration, Topical; Adult; Aged; Apatites; Biguanides; Collagen; Disinfectants; Drug Combinations; Female; Humans; Male; Middle Aged; Osteomyelitis; Secondary Prevention; Surgical Wound Infection; Treatment Outcome; Young Adult | 2009 |
Successful treatment of Scedosporium aurantiacum osteomyelitis in an immunocompetent patient.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Cellulitis; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompromised Host; Leg Injuries; Male; Mycoses; Osteomyelitis; Pseudomonas aeruginosa; Scedosporium; Sequence Analysis, DNA; Staphylococcus aureus | 2007 |